Sponsor Pipeline

Servier Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
1
Phase 3
5
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-23 NCT07722312 S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A… Phase 1/2 Not Yet Recruiting
2026-07-22 NCT07719348 A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06780930 Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or… Residual or Recurrent Grade 2 IDH Mutant Glioma Active, Not Recruiting
Phase 2
NCT06081829 A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable… Cholangiocarcinoma Non-resectable Active, Not Recruiting
Phase 1/2
NCT07719348 A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid… Acute Myeloid Leukemia Not Yet Recruiting
NCT07722312 S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A… Relapsed or Refractory Acute Leukemia Not Yet Recruiting
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2) Cholangiocarcinoma (1) Glioma (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Servier's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free